Get On the Biotech Bandwagon with ETFs

The stock market isn’t just a big block of stone that moves all at once. So I’m always looking for market leadership. Even in a strong market, a smaller group is almost always breaking ahead.

And right now, biotechnology stocks are moving up faster than most anything else. Just last week Human Genome Sciences (HGSI) surged more than 400 percent thanks to successful trials of a new lupus drug.

Biotechnology is a fascinating sector, one that’s made (and lost) a lot of money for millions of investors in recent decades. That’s why, in my opinion, you should become familiar with this industry.

What…

Biotech Stocks: Opportunities abound for Osiris Therapeutics (OSIR:NASDAQ)

‘This Maryland-based biotechnology firm develops treatments for conditions as varied as Crohn’s disease, knee arthritis, tissue damage, life-threatening Graft-versus-host disease and acute radiation syndrome.’ – Laura Cadden

Osiris Therapeutics, Inc. creates therapeutic drugs from human mesenchymal stem cells (MSCs) retrieved from bone marrow donated by healthy adult volunteers.

Bone regeneration = big bucks

Earlier this month, Osiris announced the sale of its Osteocel unit to NuVasive for $85 million.

Osteocel promotes bone regeneration and is used in spinal fusion and other orthopedic procedures.

This deal provides Osiris with the money and ability to focus on the next generation of revolutionary products… products like Chondrogen, which works…